Sho Sato

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Placebo Controlled

Metastatic Breast Cancer

Top Venues

Journal of gynecologic oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Sho Sato, Takahito Miura, Aiko Ogasawara, Daisuke Shintani, Shogo Yamaguchi, Hiroaki Inui, Akiko Yoshinaga, Masahiko Nishiyama, Momomi Tsugane, Kosei Hasegawa
Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential. Journal of gynecologic oncology (2024)
Sho Sato, Tadahiro Shoji, Ami Jo, Haruka Otsuka, Marina Abe, Shunsuke Tatsuki, Yohei Chiba, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer. Cancers 16 (14) (2024)
Shigehiro Yagishita, Tadaaki Nishikawa, Hiroshi Yoshida, Daisuke Shintani, Sho Sato, Maiko Miwa, Mikiko Suzuki, Masanori Yasuda, Yusuke Ogitani, Takahiro Jikoh, Kan Yonemori, Kosei Hasegawa, Akinobu Hamada
Co-clinical study of [fam-] trastuzumab deruxtecan (DS8201a) in patient-derived xenograft models of uterine carcinosarcoma and its association with clinical efficacy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yuji Ikeda, Sho Sato, Akira Yabuno, Daisuke Shintani, Aiko Ogasawara, Maiko Miwa, Makda Getachew Zewde, Takashi Miyamoto, Keiichi Fujiwara, Yusuke Nakamura, Kosei Hasegawa
High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo. Journal of gynecologic oncology 31 (6) (2021)